{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:39:58Z","timestamp":1788316798531,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Autoimmun Highlights"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13317-016-0074-1","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T04:56:50Z","timestamp":1455253010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Beh\u00e7et\u2019s disease physiopathology: a contemporary review"],"prefix":"10.1007","volume":"7","author":[{"given":"Mohamad J.","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Six","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"3\u20134","key":"74_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gon\u00e7alves O, Valente J (2009) Beh\u00e7et\u2019s disease\u2014a contemporary review. J Autoimmun 32(3\u20134):178\u2013188","journal-title":"J Autoimmun"},{"issue":"3","key":"74_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Beh\u00e7et\u2019s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54(3):213\u2013220","journal-title":"Tissue Antigens"},{"issue":"5","key":"74_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A et al (2007) Anti-TNF therapy in the management of beh\u00e7et\u2019s disease-review and basis for recommendations. Rheumatology (Oxford) 46(5):736\u2013741","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"74_CR4","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P (2010) Mortality in Beh\u00e7et\u2019s disease. Arthritis Rheum 62(9):2806\u20132812","journal-title":"Arthritis Rheum"},{"issue":"17","key":"74_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N (1999) Beh\u00e7et\u2019s disease. N Engl J Med 341(17):1284\u20131291","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"74_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis PP (2002) Beh\u00e7et\u2019s disease: a new target for anti-tumor necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):51\u201353","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"74_CR7","first-page":"259","volume":"30","author":"H Yazici","year":"1977","unstructured":"Yazici H, Akokan G, Yal\u00e7in B, M\u00fcft\u00fco\u011flu A (1977) The high prevalence of HLA-B5 in Beh\u00e7et\u2019s disease. Clin Exp Immunol 30(2):259\u2013261","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"74_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Beh\u00e7et\u2019s disease activity index. Rheumatology (Oxford) 43(1):73\u201378","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"74_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1172-9-42","volume":"27","author":"L Savey","year":"2014","unstructured":"Savey L, Resche-Rigon M, Wechsler B, Comarmond C, Piette JC, Cacoub P, Saadoun D (2014) Ethnicity and association with disease manifestations and mortality in Beh\u00e7et\u2019s disease. Orphanet J Rare Dis 27(9):42","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"74_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/ard.59.8.622","volume":"59","author":"A G\u00fcl","year":"2000","unstructured":"G\u00fcl A, Inan\u00e7 M, Ocal L, Aral O, Koni\u00e7e M (2000) Familial aggregation of Beh\u00e7et\u2019s disease in turkey. Ann Rheum Dis 59(8):622\u2013625","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"74_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet 42(8):698\u2013702","journal-title":"Nat Genet"},{"issue":"12","key":"74_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/acr.20308","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi Huong D, Resche-Rigon M et al (2010) Azathioprine in severe uveitis of Beh\u00e7et\u2019s disease. Arthritis Care Res (Hoboken). 62(12):1733\u20131738","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"8","key":"74_CR13","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/art.34450","volume":"64","author":"AC Desbois","year":"2012","unstructured":"Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong D Le T, Amoura Z et al (2012) Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease. Arthritis Rheum 64(8):2753\u20132760","journal-title":"Arthritis Rheum"},{"issue":"4","key":"74_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3129\/i08-080","volume":"43","author":"LI Kump","year":"2008","unstructured":"Kump LI, Moeller KL, Reed GF, Kurup SK, Nussenblatt RB, Levy-Clarke GA (2008) Beh\u00e7et\u2019s disease: comparing 3 decades of treatment response at the national eye institute. Can J Ophthalmol 43(4):468\u2013472","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"74_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","volume":"48","author":"E Alpsoy","year":"2007","unstructured":"Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Beh\u00e7et\u2019s disease. Yonsei Med J 48(4):573\u2013585","journal-title":"Yonsei Med J"},{"issue":"4","key":"74_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000074113","volume":"207","author":"E Alpsoy","year":"2003","unstructured":"Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Beh\u00e7et\u2019s disease. Dermatology 207(4):354\u2013356","journal-title":"Dermatology"},{"issue":"2","key":"74_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A (2009) Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192","journal-title":"Lancet Neurol"},{"issue":"6","key":"74_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1440-1789.2006.00734.x","volume":"26","author":"Y Arai","year":"2006","unstructured":"Arai Y, Kohno S, Takahashi Y, Miyajima Y, Tsutusi Y (2006) Autopsy case of neuro-Beh\u00e7et\u2019s disease with multifocal neutrophilic perivascular inflammation. Neuropathology 26(6):579\u2013585","journal-title":"Neuropathology"},{"issue":"2","key":"74_CR19","first-page":"55","volume":"16","author":"MG Hadfield","year":"1997","unstructured":"Hadfield MG, Aydin A, Lippman HR, Sanders KM (1997) Neuro-Beh\u00e7et\u2019s disease. Clin Neuropathol 16(2):55\u201360","journal-title":"Clin Neuropathol"},{"issue":"5","key":"74_CR20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.38351","volume":"66","author":"N Noel","year":"2014","unstructured":"Noel N, Bernard R, Wechsler B, Resche-Rigon M, Depaz R, Le Thi Huong Boutin D et al (2014) Long-term outcome of neuro-Beh\u00e7et\u2019s disease. Arthritis Rheum 66(5):1306\u20131314","journal-title":"Arthritis Rheum"},{"issue":"6","key":"74_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11910-012-0316-1","volume":"12","author":"D Kidd","year":"2012","unstructured":"Kidd D (2012) Neurological complications of Beh\u00e7et\u2019s syndrome. Curr Neurol Neurosc Rep 12(6):675\u2013679","journal-title":"Curr Neurol Neurosc Rep"},{"issue":"2","key":"74_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C et al (2001) Beh\u00e7et\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95\u2013103","journal-title":"J Neurol"},{"issue":"1","key":"74_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Beh\u00e7et\u2019s syndrome. J Neurol Sci 272(1):99\u2013105","journal-title":"J Neurol Sci"},{"issue":"4","key":"74_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.24393","volume":"61","author":"D Saadoun","year":"2009","unstructured":"Saadoun D, Wechsler B, Resche-Rigon M, Trad S, Le Thi Huong D, Sbai A et al (2009) Cerebral venous thrombosis in Beh\u00e7et\u2019s disease. Arthritis Rheum 61(4):518\u2013526","journal-title":"Arthritis Rheum"},{"issue":"11","key":"74_CR25","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G (1999) Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. Brain 122(11):2171\u20132182","journal-title":"Brain"},{"issue":"5","key":"74_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00234-003-0952-x","volume":"45","author":"O Kizilkilic","year":"2003","unstructured":"Kizilkilic O, Albayram S, Adaletli I, Ak H, Islak C, Kocer N (2003) Endovascular treatment of Beh\u00e7et\u2019s disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 45(5):328\u2013334","journal-title":"Neuroradiology"},{"issue":"2","key":"74_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s004150050317","volume":"246","author":"\u00d6 \u00d6ktem-Tan\u00f6r","year":"1999","unstructured":"\u00d6ktem-Tan\u00f6r \u00d6, Baykan-Kurt B, G\u00fcrvit IH, Akman-Demir G, Serdaro\u011flu P (1999) Neuropsychological follow-up of 12 patients with neuro-Beh\u00e7et\u2019s disease. J Neurol 246(2):113\u2013119","journal-title":"J Neurol"},{"issue":"1","key":"74_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MD.0b013e3182428126","volume":"91","author":"D Saadoun","year":"2012","unstructured":"Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K et al (2012) Long-term outcome of arterial lesions in Beh\u00e7et\u2019s disease: a series of 101 patients. Medicine (Baltimore) 91(1):18\u201324","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"74_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.revmed.2013.12.002","volume":"35","author":"A Desbois","year":"2014","unstructured":"Desbois A, Wechsler B, Cluzel P, Helft G, Boutin D, Piette JC et al (2014) Cardiovascular involvement in Beh\u00e7et\u2019s disease. Rev Med Int 35(2):103\u2013111","journal-title":"Rev Med Int"},{"issue":"5","key":"74_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","volume":"42","author":"U Tursen","year":"2003","unstructured":"Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 turkish patients with Beh\u00e7et\u2019s disease. Int J Dermatol 42(5):346\u2013351","journal-title":"Int J Dermatol"},{"issue":"1","key":"74_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82(1):60\u201376","journal-title":"Medicine"},{"issue":"1","key":"74_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-014-0153-1","volume":"9","author":"A Desbois","year":"2014","unstructured":"Desbois A, Rautou P, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M et al (2014) Beh\u00e7et\u2019s disease in Budd-Chiari syndrome. Orphanet J Rare Dis 9(1):104","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"74_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","volume":"33","author":"V Hamuryudan","year":"1994","unstructured":"Hamuryudan V, Yurdakul S, Moral F et al (1994) Pulmonary arterial aneurysms in beh\u00e7et\u2019s syndrome: a report of 24 cases. Br J Rheumatol 33(1):48\u201351","journal-title":"Br J Rheumatol"},{"issue":"3","key":"74_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","volume":"128","author":"G Geri","year":"2011","unstructured":"Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D et al (2011) Critical role of IL-21 in modulating Th17 and regulatory T cells in Beh\u00e7et\u2019s disease. J Allergy Clin Immunol 128(3):655","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"74_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1191\/0961203305lu2208oa","volume":"14","author":"F Atzeni","year":"2005","unstructured":"Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C (2005) Beh\u00e7et\u2019s disease and cardiovascular involvement. Lupus 14(9):723\u2013726","journal-title":"Lupus"},{"issue":"4","key":"74_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.revmed.2007.09.031","volume":"29","author":"MA Ait Badi","year":"2008","unstructured":"Ait Badi MA, Zyani M, Kaddouri S, Niamane R, Hda A, Algayres J (2008) Les manifestations articulaires de la maladie de Beh\u00e7et. \u00c0 propos de 79 cas. Rev Med Int 29(4):277\u2013282","journal-title":"Rev Med Int"},{"issue":"4","key":"74_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","volume":"27","author":"VG Kaklamani","year":"1998","unstructured":"Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Beh\u00e7et\u2019s disease. Sem Arthritis Rheum 27(4):197\u2013217","journal-title":"Sem Arthritis Rheum"},{"key":"74_CR38","unstructured":"Kastner DL. Intermittent and periodic arthritic syndromes. In: Koopman WJ (ed.) Arthritis and allied conditions: a textbook of rheumatology. Vol. 1. 13th ed. Baltimore: Williams and Wilkins; 1997:1279\u20131306"},{"issue":"12","key":"74_CR39","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1111\/j.1572-0241.1998.02633.x","volume":"93","author":"IL Beales","year":"1998","unstructured":"Beales IL (1998) Gastrointestinal involvement in Beh\u00e7et\u2019s syndrome. Am J Gastroenterol 93(12):2633","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"74_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","volume":"18","author":"SE Marshall","year":"2004","unstructured":"Marshall SE (2004) Beh\u00e7et\u2019s disease. Best Pract Res Clin Rheumatol 18(3):291\u2013311","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"74_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3349\/ymj.1997.38.6.455","volume":"38","author":"KS Lee","year":"1997","unstructured":"Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WJ, Chi HS (1997) Surgical treatment of intestinal Beh\u00e7et\u2019s disease. Yonsei Med J 38(6):455\u2013460","journal-title":"Yonsei Med J"},{"key":"74_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"issue":"3","key":"74_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.410360309","volume":"36","author":"J Link","year":"1994","unstructured":"Link J, S\u00f6derstr\u00f6m M, Olsson T, H\u00f6jeberg B, Ljungdahl A, Link H (1994) Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann Neurology 36(3):379\u2013386","journal-title":"Ann Neurology"},{"issue":"1","key":"74_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","volume":"53","author":"SB Cho","year":"2012","unstructured":"Cho SB, Cho S, Bang D (2012) New insights in the clinical understanding of Beh\u00e7et\u2019s disease. Yonsei Med J 53(1):35\u201342","journal-title":"Yonsei Med J"},{"issue":"8697","key":"74_CR45","first-page":"1078","volume":"335","author":"International study group for Beh\u00e7et\u2019s disease","year":"1990","unstructured":"International study group for Beh\u00e7et\u2019s disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"key":"74_CR46","first-page":"74","volume":"43","author":"\u00dc T\u00fcrsen","year":"2009","unstructured":"T\u00fcrsen \u00dc (2009) Activation markers in Beh\u00e7et disease. Turkderm 43:74\u201386","journal-title":"Turkderm"},{"key":"74_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373\u2013384","journal-title":"Nat Immunol"},{"issue":"10","key":"74_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M Menthon de","year":"2009","unstructured":"de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A (2009) HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 61(10):1287\u20131296","journal-title":"Arthritis Rheum"},{"issue":"9","key":"74_CR49","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","volume":"100","author":"S Ohno","year":"1982","unstructured":"Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-Bw51 with Beh\u00e7et\u2019s disease. Arch Ophthalmol 100(9):1455\u20131458","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"74_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13317-013-0047-6","volume":"4","author":"FZ Shahneh","year":"2013","unstructured":"Shahneh FZ, Hamzavi F, Bayazi B, Bandehagh A, Baradaran B (2013) New insights into HLA class I association to Beh\u00e7et\u2019s syndrome in Iranian Azari patients. Auto Immun Highlights 4(3):101\u2013102","journal-title":"Auto Immun Highlights"},{"key":"74_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BOR.0000000000000003","volume":"26","author":"A G\u00fcl","year":"2014","unstructured":"G\u00fcl A (2014) Genetics of Beh\u00e7et\u02bcs disease: lessons learned from genomewide association studies. Curr Opin Rheumatol 26:56\u201363","journal-title":"Curr Opin Rheumatol"},{"key":"74_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Beh\u00e7et\u2019s disease: a comprehensive review. J Autoimmun 64:137\u2013148","journal-title":"J Autoimmun"},{"key":"74_CR53","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello MJ, Kirino Y, de Paul Bakker IW, G\u00fcl A, Kastner DL, Remmers EF (2014) Beh\u00e7et disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci USA 111:8867\u20138872","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"74_CR54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","volume":"36","author":"M Kobayashi","year":"2000","unstructured":"Kobayashi M, Ito M, Nakagawa A, Matsushita M, Nishikimi N, Sakurai T, Nimura Y (2000) Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Beh\u00e7et disease. Histopathology 36(4):362\u2013371","journal-title":"Histopathology"},{"issue":"1","key":"74_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/08830189709116842","volume":"14","author":"T Lehner","year":"1997","unstructured":"Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et\u2019s disease. Int Rev Immunol 14(1):21\u201332","journal-title":"Int Rev Immunol"},{"issue":"4","key":"74_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C et al (2015) Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun Rev 14(4):269\u2013276","journal-title":"Autoimmun Rev"},{"issue":"2","key":"74_CR57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","volume":"140","author":"S Hirohata","year":"1992","unstructured":"Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL6 and interferon-\u03b3 by T cells from patients with Beh\u00e7et\u2019s disease. Cell Immunol 140(2):410\u2013419","journal-title":"Cell Immunol"},{"key":"74_CR58","first-page":"301","volume":"296","author":"Matzinger P The","year":"2002","unstructured":"The Matzinger P, Model Danger (2002) A Renewed Sense of Self. Science. 296:301\u2013305","journal-title":"A Renewed Sense of Self. Science."},{"key":"74_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1126\/science.1068883","volume":"296","author":"R Medzhitov","year":"2002","unstructured":"Medzhitov R, Janeway CA (2002) Decoding the patterns of self and non self by the innate immune system. Science 296:298\u2013300","journal-title":"Science"},{"key":"74_CR60","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli H (2006) Autoimmunity vs autoinflammation in Behcet\u2019s disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 45:1461\u20131465","journal-title":"Rheumatology (Oxford)"},{"key":"74_CR61","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1242\/jcs.149831","volume":"127","author":"P Cohen","year":"2014","unstructured":"Cohen P (2014) The TLR and IL-1 signalling network at a glance. J Cell Sci 127:2383\u20132390","journal-title":"J Cell Sci"},{"issue":"1","key":"74_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2007.09.041","volume":"267","author":"S Hirohata","year":"2008","unstructured":"Hirohata S (2008) Histopathology of central nervous system lesions in Beh\u00e7et\u2019s disease. J Neurol Sci 267(1):41\u201347","journal-title":"J Neurol Sci"},{"issue":"7","key":"74_CR63","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri1130","volume":"3","author":"G Kidd","year":"2003","unstructured":"Kidd G, Kivis\u00e4kk P, Ransohoff RM (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3(7):569\u2013581","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"74_CR64","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF et al (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-6. J Immunol 173(9):5361","journal-title":"J Immunol"},{"issue":"1","key":"74_CR65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172(1):146\u2013155","journal-title":"Am J Pathol"},{"issue":"1","key":"74_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23(1):447\u2013485","journal-title":"Annu Rev Immunol"},{"issue":"26","key":"74_CR67","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","volume":"114","author":"C Bucher","year":"2009","unstructured":"Bucher C, Koch L, Vogtenhuber C, Goren E, Munger M, Panoskaltsis-Mortari A et al (2009) IL-21 blockade reduces graft-versus-host-disease mortality by supporting inducible T regulatory cell generation. Blood 114(26):5375\u20135384","journal-title":"Blood"},{"issue":"6652","key":"74_CR68","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"A O\u2019Garra","year":"1997","unstructured":"O\u2019Garra A, Rouleau M, Antonenko S, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737\u2013742","journal-title":"Nature"},{"issue":"3","key":"74_CR69","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","volume":"26","author":"A Laurence","year":"2007","unstructured":"Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB et al (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26(3):371\u2013381","journal-title":"Immunity"},{"issue":"1","key":"74_CR70","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25(1):821\u2013852","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"74_CR71","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282(13):9358\u20139363","journal-title":"J Biol Chem"},{"issue":"9","key":"74_CR72","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.4049\/jimmunol.181.9.6536","volume":"181","author":"JW Lee","year":"2008","unstructured":"Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K, Straus DS (2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 181(9):6536","journal-title":"J Immunol"},{"key":"74_CR73","unstructured":"Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010; 2009;30(1):80\u20139"},{"issue":"10","key":"74_CR74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton Chambrun de","year":"2012","unstructured":"de Pineton Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D (2012) New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun Rev 11(10):687\u2013698","journal-title":"Autoimmun Rev"},{"issue":"7","key":"74_CR75","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121(7):906\u2013915","journal-title":"Circulation"},{"issue":"1","key":"74_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/08830189709116847","volume":"14","author":"T Sakane","year":"1997","unstructured":"Sakane T (1997) New perspective on Beh\u00e7et\u2019s disease. Int Rev Immunol 14(1):89\u201396","journal-title":"Int Rev Immunol"},{"issue":"10","key":"74_CR77","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human Th17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173\u20131175","journal-title":"Nat Med"},{"key":"74_CR78","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V et al (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365:2067\u20132077","journal-title":"N Engl J Med"},{"issue":"7152","key":"74_CR79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K et al (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152):480\u2013483","journal-title":"Nature"},{"issue":"5","key":"74_CR80","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.4049\/jimmunol.174.5.2696","volume":"174","author":"TL Vollmer","year":"2005","unstructured":"Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, Shi F (2005) Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174(5):2696\u20132701","journal-title":"J Immunol"},{"issue":"9","key":"74_CR81","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ni1500","volume":"8","author":"A Brustle","year":"2007","unstructured":"Brustle A, Heink S, Huber M, Rosenpl\u00e4nter C, Stadelmann C, Yu P et al (2007) The development of inflammatory Th-17 cells requires interferon-regulatory factor 4. Nat Immunol 8(9):958\u2013966","journal-title":"Nat Immunol"},{"issue":"6","key":"74_CR82","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A et al (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899\u2013911","journal-title":"Immunity"},{"issue":"5","key":"74_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"D Bottinelli","year":"2009","unstructured":"Bottinelli D, Uccelli A, Engelhardt B, Benvenuto F, Bottinelli D, Lira S et al (2009) C-C chemokine receptor 6-regulated entry of T H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10(5):514\u2013523","journal-title":"Nat Immunol"},{"issue":"1","key":"74_CR84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5","volume":"52","author":"B Engelhardt","year":"2001","unstructured":"Engelhardt B, Wolburg-Buchholz K, Wolburg H (2001) Involvement of the choroid plexus in central nervous system inflammation. Micros Res Tech 52(1):112\u2013129","journal-title":"Micros Res Tech"},{"issue":"6","key":"74_CR85","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","volume":"29","author":"Q Chen","year":"2008","unstructured":"Chen Q, Yang W, Gupta S, Biswas P, Smith P, Bhagat G, Pernis AB (2008) IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 29(6):899\u2013911","journal-title":"Immunity"},{"issue":"11","key":"74_CR86","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1002\/eji.200737766","volume":"37","author":"MC Fantini","year":"2007","unstructured":"Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF et al (2007) IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 37(11):3155\u20133163","journal-title":"Eur J Immunol"},{"issue":"2","key":"74_CR87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1191\/135245899678847275","volume":"5","author":"D Matusevicius","year":"1999","unstructured":"Matusevicius D, Kivis\u00e4kk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5(2):101\u2013104","journal-title":"Mult Scler"},{"key":"74_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clim.2014.01.009","volume":"152","author":"PK Dagur","year":"2014","unstructured":"Dagur PK, Biancotto A, Stansky E, Sen HN, Nussenblatt RB, McCoy JP (2014) Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). Clin Immunol 152:36\u201347","journal-title":"Clin Immunol"},{"issue":"6","key":"74_CR89","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of pro-inflammatory IL-17+ T helper cells. Cell 126(6):1121","journal-title":"Cell"},{"issue":"4","key":"74_CR90","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.176.4.1091","volume":"176","author":"RA Seder","year":"1992","unstructured":"Seder RA, Paul WE, Davis MM, de Fazekas St Groth B (1992) The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 176(4):1091\u20131098","journal-title":"J Exp Med"},{"issue":"11","key":"74_CR91","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13238-013-3088-8","volume":"4","author":"X Wu","year":"2013","unstructured":"Wu X, Tan Y, Xing Q, Wang S (2013) IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation. Protein Cell 4(11):863\u2013871","journal-title":"Protein Cell"},{"issue":"27","key":"74_CR92","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1021\/bi0202023","volume":"41","author":"T Habib","year":"2002","unstructured":"Habib T, Senadheera S, Weinberg K, Kaushansky K (2002) The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41(27):8725","journal-title":"Biochemistry"},{"issue":"5","key":"74_CR93","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.autrev.2014.12.009","volume":"14","author":"M Touzot","year":"2015","unstructured":"Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D (2015) IFN-\u03b1 induces IL-10 production and tilt the balance between Th1 and Th17 in Beh\u00e7et disease. Autoimmun Rev 14(5):370\u2013375","journal-title":"Autoimmun Rev"},{"issue":"7","key":"74_CR94","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.autrev.2014.01.056","volume":"13","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Wechsler B, Bodaghi B, Cacoub P, Saadoun D (2014) Biotherapies in Beh\u00e7et\u2019s disease. Autoimmun Rev 13(7):762\u2013769","journal-title":"Autoimmun Rev"},{"issue":"3","key":"74_CR95","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10384-006-0424-z","volume":"51","author":"M Takamoto","year":"2007","unstructured":"Takamoto M, Kaburaki T, Numaga J, Fujino Y, Kawashima H (2007) Long-term infliximab treatment for beh\u00e7et\u2019s disease. Jpn J Ophthalmol 51(3):239\u2013240","journal-title":"Jpn J Ophthalmol"},{"key":"74_CR96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/0-306-48382-3_75","volume":"528","author":"A Sba\u00ef","year":"2003","unstructured":"Sba\u00ef A, Wechsler B, Duhaut P, Du-Boutin LT, Amoura Z, Cacoub P et al (2003) Neuro-Beh\u00e7et\u2019s disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. Adv Exp Med Biol 528:371\u2013376","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"74_CR97","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.revmed.2009.09.002","volume":"30","author":"B Wechsler","year":"2009","unstructured":"Wechsler B, L\u00ea Thi Huong DB, Saadoun D (2009) EULAR recommendations for the management of Beh\u00e7et\u2019s disease: evidence-based or experience-based medicine. Rev Med Interne 30(11):939\u2013941","journal-title":"Rev Med Interne"},{"key":"74_CR98","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","volume":"372","author":"G Hatemi","year":"2015","unstructured":"Hatemi G, Melikoglu M, Tunc R et al (2015) Apremilast for Beh\u00e7et\u2019s syndrome\u2013a phase 2, placebo-controlled study. N Engl J Med 372:1510","journal-title":"N Engl J Med"}],"container-title":["Autoimmunity Highlights"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13317-016-0074-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13317-016-0074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13317-016-0074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13317-016-0074-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:31Z","timestamp":1559490271000},"score":1,"resource":{"primary":{"URL":"https:\/\/autoimmunhighlights.biomedcentral.com\/articles\/10.1007\/s13317-016-0074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s13317-016-0074-1","relation":{},"ISSN":["2038-0305","2038-3274"],"issn-type":[{"value":"2038-0305","type":"print"},{"value":"2038-3274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"26 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"4"}}